Skip to main content

Peer Review reports

From: Co-delivery of doxycycline and rifampicin using CdTe-labeled poly (lactic-co-glycolic) acid for treatment of Brucella melitensis infection

Original Submission
10 Dec 2023 Submitted Original manuscript
27 Dec 2023 Reviewed Reviewer Report
30 Dec 2023 Reviewed Reviewer Report
4 Jan 2024 Reviewed Reviewer Report
3 Feb 2024 Author responded Author comments - Mohammad Taheri
Resubmission - Version 2
3 Feb 2024 Submitted Manuscript version 2
10 Feb 2024 Author responded Author comments - Mohammad Taheri
Resubmission - Version 3
10 Feb 2024 Submitted Manuscript version 3
13 Feb 2024 Author responded Author comments - Mohammad Taheri
Resubmission - Version 4
13 Feb 2024 Submitted Manuscript version 4
16 Feb 2024 Author responded Author comments - Mohammad Taheri
Resubmission - Version 5
16 Feb 2024 Submitted Manuscript version 5
21 Feb 2024 Reviewed Reviewer Report
22 Feb 2024 Reviewed Reviewer Report
28 Feb 2024 Reviewed Reviewer Report
18 Apr 2024 Author responded Author comments - Mohammad Taheri
Resubmission - Version 6
18 Apr 2024 Submitted Manuscript version 6
19 Apr 2024 Reviewed Reviewer Report
19 Apr 2024 Reviewed Reviewer Report
21 Apr 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
22 Apr 2024 Editorially accepted
15 May 2024 Article published 10.1186/s13065-024-01200-8

You can find further information about peer review here.

Back to article page